Living with Progeria by Stamsnijder, Marjet
ORAL PRESENTATION Open Access
Living with Progeria
Marjet Stamsnijder
From 5th European Conference on Rare Diseases (ECRD 2010)
Krakow, Poland. 13-15 May 2010
Children with Progeria can be an inspiration to those
who meet them.
Mission
T h eP r o g e r i aF a m i l yC i r c l ei sap a r e n t s ’ organisation
and network that supports European Progeria children
and their families in several ways. The objectives are
fourfold:
Meetings
First, the foundation organises annual meetings for all
European children and their families. These are impor-
tant highlights, because of the rarity of the disease chil-
d r e nn e v e rs e eo t h e rp a t i e n t s .A l s of o rt h ep a r e n t s ,
mutual contact proved very valuable. Meetings are a
source of joy in which the children find much self-
esteem. Also they have the opportunity to speak with
specialist physicians, and to exchange actual information
about Progeria.
Information
As a second objective, the Progeria Family Circle offers
parents of European children advice and support where
needed. The value of emotional support and assistance
of parents with experience is difficult to estimate. We
bring family doctors and physiotherapists into contact
with specialists in the field of Progeria.
Support
Progeria families come from different countries with dif-
ferent social, political and religious backgrounds. It is
sometimes a big problem for families to give their chil-
dren enough care. We also look for solutions to indivi-
dual households to help them as directly as possible. If
necessary, we seek financial support, when needed for
the welfare of the child.
Medical developments
The fourth objective focuses on the medical field. The
aim is to support better and faster recognition of symp-
toms and problems in new, but also known patients.
Scientific research and new therapies have made much
progress in the past few years. An experimental treat-
ment with Farnesyltransferase inhibitors (FTIS) started in
Boston, and European children were offered a different
therapy with a combination of statines and amino-
biphosfonate in Marseille. The last combination of
medication is also now used in Boston.
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